ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
RegeneRX Biopharmaceuticals Inc (CE)

RegeneRX Biopharmaceuticals Inc (CE) (RGRX)

0.0014
0.00
(0.00%)
Closed February 28 4:00PM
Upgrade to Real time
0.0014
0.000.00%
Rendering Error

RegeneRx highlights research showing Thymosin Beta 4's ability to pro…

To read the full story on Seeking Alpha, click here.

Microcap RegeneRx surges 17% on regulatory development for ophthalmic…

To read the full story on Seeking Alpha, click here.

RegeneRx JV provides regulatory timeline update for RGN-259 BLA

To read the full story on Seeking Alpha, click here.

RegeneRx gives updated timeline on late-stage ARISE-3 trial

To read the full story on Seeking Alpha, click here.

RegeneRx posts topline results of ARISE-3 dry eye trial

To read the full story on Seeking Alpha, click here.

Clinical Trial Demonstrates Elevated Thymosin Beta 4 Plasma Levels ar…

Clinical Trial Demonstrates Elevated Thymosin Beta 4 Plasma Levels are...

RegeneRx to Present at 2 Investor Conferences

RegeneRx to Present at 2 Investor Conferences PR Newswire ROCKVILLE, Md...

Complete Data from RegeneRx Phase II Dry Eye Trial Published in Curre…

Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current...

Researchers Report that Long-Term Administration of Thymosin B4 in a …

Researchers Report that Long-Term Administration of Thymosin B4 in a...

News
RGRX News
Newswire
PriceSizeTypeTime
Trades

Your Recent History

Delayed Upgrade Clock